Enzymes in Drug Discovery Summit - Global Technology Community Bio
February 22-23, 2018 | San Diego, CA.
GTCbio conferences aim to facilitate transformational platforms that would have a significant impact on scientific research, drug development and healthcare. Identifying and validating new targets is a critical starting point and often times a daunting inflection point in drug development. While there is continuous innovation and invention of new assays and screening technologies, it is important to understand how these technologies will help with new and existing targets. Protein Kinases have long been an important target in several diseases and we will discuss new developments in this area at our 2018 Enzymes in Drug Discovery Summit. We will also focus on advances in Ubiquitin and Protease targeted therapies.
Please join us to be part of an exciting platform at the Enzymes in Drug Discovery Summit, which will take place February 22-23, 2018 in San Diego, CA.
This summit will feature the following four targeted areas:
Protein Kinases in Drug Discovery
Novel Approaches, Tools and Technologies in Kinase Drug Discovery
Kinome Selectivity & Clinical Translation
Ubiquitin Research & Drug Discovery
Novel Drug Targets in the Ubiquitin System
Advances in Ubiquitin-like Modifications
Epigenetic Enzymes in Drug Discovery
Epigenetic Modification &Transcriptional Regulation
Novel Therapeutic Targets &Translational Studies
Protease Inhibitors in Drug Discovery
Chemistry and Drug Design for Protease Inhibitors
Protease Inhibitors in Translational Research
In addition to scientific presentations, dedicated networking sessions will allow you to connect and form new relationships with colleagues from both the private and public sector.
GTCbio encourages attendees to showcase their research at the conference by presenting a poster. The top 2-3 submitted posters will also be selected to give short oral presentations as part of the meeting program. Slots fill up quickly so submit yours online ASAP!